This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Nrg Therapeutics Ltd, Iteos Belgium Sa. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Michael Rowley - Innovator in mPTP Inhibitors
Introduction
Michael Rowley is a notable inventor based in Chelmsford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for the mitochondrial permeability transition pore (mPTP). His work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Michael Rowley holds 1 patent related to his invention titled "Inhibitors of mPTP." This invention pertains to compounds of formula (I) and explores various related aspects that could potentially lead to breakthroughs in treatment methodologies.
Career Highlights
Throughout his career, Michael has been associated with NRG Therapeutics Ltd, where he has played a pivotal role in research and development. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Michael has collaborated with talented individuals such as Tammy Ladduwahetty and Jan Kulagowski. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in research.
Conclusion
Michael Rowley's contributions to the field of mPTP inhibitors highlight his dedication to innovation and the advancement of medical science. His work continues to inspire future research and development in this critical area.